Robert O. Williams

16.7k total citations · 3 hit papers
295 papers, 12.3k citations indexed

About

Robert O. Williams is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Food Science. According to data from OpenAlex, Robert O. Williams has authored 295 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pharmaceutical Science, 88 papers in Pulmonary and Respiratory Medicine and 69 papers in Food Science. Recurrent topics in Robert O. Williams's work include Drug Solubulity and Delivery Systems (139 papers), Advanced Drug Delivery Systems (81 papers) and Inhalation and Respiratory Drug Delivery (79 papers). Robert O. Williams is often cited by papers focused on Drug Solubulity and Delivery Systems (139 papers), Advanced Drug Delivery Systems (81 papers) and Inhalation and Respiratory Drug Delivery (79 papers). Robert O. Williams collaborates with scholars based in United States, Egypt and China. Robert O. Williams's co-authors include Keith P. Johnston, Jay I. Peters, James W. McGinity, Dave A. Miller, Chris Brough, Wei Yang, Zhengrong Cui, True L. Rogers, Jiahui Hu and Jason T. McConville and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.

In The Last Decade

Robert O. Williams

289 papers receiving 11.9k citations

Hit Papers

Inhaled nanoparticles—A current review 2008 2026 2014 2020 2008 2011 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhaled nanoparticles—A current review
    2008 481 citations Jay I. Peters, Robert O. Williams et al. International Journal of Pharmaceutics profile →
  2. Influence of particle size on regional lung deposition – What evidence is there?
    2011 447 citations Jay I. Peters, Robert O. Williams et al. International Journal of Pharmaceutics profile →
  3. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update
    2017 339 citations Robert O. Williams et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert O. Williams United States 59 6.9k 2.8k 2.6k 2.5k 2.1k 295 12.3k
Ali Nokhodchi United Kingdom 59 6.2k 0.9× 1.2k 0.4× 2.4k 0.9× 1.4k 0.5× 1.8k 0.9× 387 11.8k
Henderik W. Frijlink Netherlands 59 3.7k 0.5× 4.1k 1.4× 815 0.3× 2.5k 1.0× 2.2k 1.1× 340 12.1k
Guy Van den Mooter Belgium 66 9.2k 1.3× 686 0.2× 4.2k 1.6× 2.5k 1.0× 1.9k 0.9× 278 14.7k
Christopher J. H. Porter Australia 74 9.9k 1.4× 979 0.3× 2.9k 1.1× 6.1k 2.4× 1.8k 0.8× 311 21.7k
Patrick Augustijns Belgium 73 8.8k 1.3× 777 0.3× 4.3k 1.7× 3.5k 1.4× 1.1k 0.5× 409 18.3k
Hans E. Junginger Netherlands 76 10.9k 1.6× 1.2k 0.4× 879 0.3× 4.7k 1.9× 1.3k 0.6× 233 17.6k
Hak‐Kim Chan Australia 77 4.2k 0.6× 11.1k 3.9× 1.8k 0.7× 3.0k 1.2× 3.5k 1.7× 541 21.4k
Hirofumi Takeuchi Japan 59 6.5k 0.9× 1.3k 0.5× 1.2k 0.5× 2.6k 1.0× 1.4k 0.7× 289 11.3k
Yoshiaki Kawashimà Japan 56 6.3k 0.9× 1.3k 0.4× 1.7k 0.7× 2.7k 1.1× 1.2k 0.6× 326 11.6k
Chuanbin Wu China 63 4.7k 0.7× 1.5k 0.5× 1.8k 0.7× 3.5k 1.4× 906 0.4× 378 13.2k

Countries citing papers authored by Robert O. Williams

Since Specialization
Citations

This map shows the geographic impact of Robert O. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert O. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert O. Williams more than expected).

Fields of papers citing papers by Robert O. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert O. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert O. Williams. The network helps show where Robert O. Williams may publish in the future.

Co-authorship network of co-authors of Robert O. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Robert O. Williams. A scholar is included among the top collaborators of Robert O. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert O. Williams. Robert O. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Hua, et al.. (2025). p53-miR-34a feedback in lung fibroblasts regulates antifibrotic effects of CSP7, nintedanib, and pirfenidone. American Journal of Physiology-Lung Cellular and Molecular Physiology. 329(4). L480–L498.
2.
Jara, Miguel O., et al.. (2025). Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug. International Journal of Pharmaceutics. 676. 125582–125582. 2 indexed citations
3.
Xu, Haiyue, Sawittree Sahakijpijarn, Chaeho Moon, et al.. (2024). Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying. International Journal of Pharmaceutics. 662. 124511–124511. 1 indexed citations
4.
Sandoval, Michael A., et al.. (2024). Reconsidering freeze-induced protein aggregation: Air bubbles as the root cause of ice-water interface stress. International Journal of Pharmaceutics. 665. 124723–124723. 1 indexed citations
5.
Jara, Miguel O., et al.. (2024). Formulation and optimization of chitosan-based amorphous fenbendazole microparticles through a design of experiment approach. International Journal of Pharmaceutics. 667(Pt A). 124872–124872. 1 indexed citations
6.
Brunaugh, Ashlee D., et al.. (2024). Essential Pharmaceutics. 1 indexed citations
7.
Yu, Yu‐Sheng, Haiyue Xu, Khaled AboulFotouh, et al.. (2024). Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system. International Journal of Pharmaceutics. 653. 123892–123892. 10 indexed citations
8.
Xu, Haiyue, Chaeho Moon, Sawittree Sahakijpijarn, et al.. (2023). Aerosolizable Plasmid DNA Dry Powders Engineered by Thin-film Freezing. Pharmaceutical Research. 40(5). 1141–1152. 10 indexed citations
9.
Jara, Miguel O. & Robert O. Williams. (2023). The challenge of repurposing niclosamide: Considering pharmacokinetic parameters, routes of administration, and drug metabolism. Journal of Drug Delivery Science and Technology. 81. 104187–104187. 12 indexed citations
10.
AboulFotouh, Khaled, Gonzalo Almanza, Yu‐Sheng Yu, et al.. (2023). Inhalable dry powders of microRNA-laden extracellular vesicles prepared by thin-film freeze-drying. International Journal of Pharmaceutics. 651. 123757–123757. 10 indexed citations
11.
AboulFotouh, Khaled, et al.. (2023). Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying. International Journal of Pharmaceutics. 650. 123688–123688. 14 indexed citations
12.
Sahakijpijarn, Sawittree, Robert Chrostowski, Chaeho Moon, et al.. (2022). Aggregation of Lactoferrin Caused by Droplet Atomization Process via a Two-Fluid Nozzle: The Detrimental Effect of Air–Water Interfaces. Molecular Pharmaceutics. 19(7). 2662–2675. 17 indexed citations
13.
Sahakijpijarn, Sawittree, Robert Chrostowski, Chaeho Moon, et al.. (2022). Entrapment of air microbubbles by ice crystals during freezing exacerbates freeze-induced denaturation of proteins. International Journal of Pharmaceutics. 628. 122306–122306. 18 indexed citations
14.
Jara, Miguel O., Zachary N. Warnken, Sawittree Sahakijpijarn, et al.. (2022). Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics. 14(12). 2568–2568. 13 indexed citations
15.
Zhang, Yajie, BreAnne MacKenzie, John J. Koleng, et al.. (2020). Development of an Excipient-Free Peptide Dry Powder Inhalation for the Treatment of Pulmonary Fibrosis. Molecular Pharmaceutics. 17(2). 632–644. 19 indexed citations
16.
Zhang, Yajie, Hairui Zhang, Debadyuti Ghosh, & Robert O. Williams. (2020). Just how prevalent are peptide therapeutic products? A critical review. International Journal of Pharmaceutics. 587. 119491–119491. 41 indexed citations
17.
Xu, Haiyue, Zachary N. Warnken, Sachin G. Thakkar, et al.. (2020). Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration. Molecular Pharmaceutics. 17(9). 3259–3269. 13 indexed citations
18.
Warnken, Zachary N., Yajie Zhang, Daniel A. Davis, et al.. (2018). A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier. Pharmaceutics. 10(2). 60–60. 23 indexed citations
19.
Warnken, Zachary N., Hugh D. C. Smyth, Daniel A. Davis, et al.. (2018). Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. Molecular Pharmaceutics. 15(4). 1392–1402. 66 indexed citations
20.
Williams, Robert O.. (1993). A Professional Development School Initiative: Indiana State University's Story.. Contemporary education. 64(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Nokhodchi Breakdown of academic impact, for papers by Henderik W. Frijlink Breakdown of academic impact, for papers by Guy Van den Mooter Breakdown of academic impact, for papers by Christopher J. H. Porter Breakdown of academic impact, for papers by Patrick Augustijns Breakdown of academic impact, for papers by Hans E. Junginger Breakdown of academic impact, for papers by Hak‐Kim Chan Breakdown of academic impact, for papers by Hirofumi Takeuchi Breakdown of academic impact, for papers by Yoshiaki Kawashimà Breakdown of academic impact, for papers by Chuanbin Wu
Rankless by CCL
2026